(18)F-Flourodeoxy-Glucose PET/Computed Tomography in Brain Tumors: Value to Patient Management and Survival Outcomes.

Journal Article (Journal Article;Review)

(18)F-flourodeoxy-glucose (FDG) PET/computed tomography (CT) is most useful in the evaluation of primary central nervous system (CNS) lymphoma, important in diagnosis, pretherapy prognosis, and therapy response evaluation. Utility in working up gliomas is less effective, and FDG PET/CT is most helpful when MR imaging is unclear. FDG avidity correlates with the grade of gliomas. FDG PET/CT can be used to noninvasively identify malignant transformation. Establishing this change in the disease process has significant effects on patient management and survival outcome.

Full Text

Duke Authors

Cited Authors

  • Wray, R; Solnes, L; Mena, E; Meoded, A; Subramaniam, RM

Published Date

  • July 2015

Published In

Volume / Issue

  • 10 / 3

Start / End Page

  • 423 - 430

PubMed ID

  • 26099676

Electronic International Standard Serial Number (EISSN)

  • 1879-9809

Digital Object Identifier (DOI)

  • 10.1016/j.cpet.2015.03.011


  • eng

Conference Location

  • United States